Insider · CIK 0001393549

Taylor Daphne

Reports to the SEC for 3 companies · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001393549

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-06	APVOAptevo Therapeutics Inc.M Exercise/Conversion	SVP, CFO	MExercise/Conversion	+638 sh	—	—	638
2026-08-06	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	SVP, CFO	MExercise/Conversion	−638 sh	—	—	0
2025-08-06	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	SVP, CFO	AAward	+11.5K sh	—	—	11,500
2025-07-17	APVOAptevo Therapeutics Inc.M Exercise/Conversion	SVP, CFO	MExercise/Conversion	+3 sh	—	—	3
2025-07-17	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	SVP, CFO	MExercise/Conversion	−3 sh	—	—	8
2025-03-04	APVOAptevo Therapeutics Inc.M Exercise/Conversion	SVP, CFO	MExercise/Conversion	+1 sh	—	—	18
2025-03-04	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	SVP, CFO	MExercise/Conversion	−1 sh	—	—	0
2025-03-02	APVOAptevo Therapeutics Inc.M Exercise/Conversion	SVP, CFO	MExercise/Conversion	+2 sh	—	—	17
2025-03-02	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	SVP, CFO	MExercise/Conversion	−2 sh	—	—	2
2024-08-08	APVOAptevo Therapeutics Inc.M Exercise/Conversion	SVP, CFO	MExercise/Conversion	+158 sh	—	—	576
2024-08-08	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	SVP, CFO	MExercise/Conversion	−158 sh	—	—	0
2024-07-17	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	SVP, CFO	AAward	+8,550 sh	—	—	8,550
2024-03-04	APVOAptevo Therapeutics Inc.M Exercise/Conversion	SVP, CFO	MExercise/Conversion	+1,584 sh	—	—	18,411
2024-03-04	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	SVP, CFO	MExercise/Conversion	−1,584 sh	—	—	1,583
2024-03-02	APVOAptevo Therapeutics Inc.M Exercise/Conversion	SVP, CFO	MExercise/Conversion	+3,667 sh	—	—	16,827
2024-03-02	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	SVP, CFO	MExercise/Conversion	−3,667 sh	—	—	7,333
2024-01-29	APVOAptevo Therapeutics Inc.M Exercise/Conversion	SVP, CFO	MExercise/Conversion	+792 sh	—	—	13,160
2024-01-29	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	SVP, CFO	MExercise/Conversion	−792 sh	—	—	0
2023-08-08	APVOAptevo Therapeutics Inc.M Exercise/Conversion	SVP, CFO	MExercise/Conversion	+6,945 sh	—	—	12,368
2023-08-08	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	SVP, CFO	MExercise/Conversion	−6,945 sh	—	—	6,944
2023-03-04	APVOAptevo Therapeutics Inc.M Exercise/Conversion	SVP, CFO	MExercise/Conversion	+1,583 sh	—	—	5,423
2023-03-04	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	SVP, CFO	MExercise/Conversion	−1,583 sh	—	—	3,167
2023-03-03	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	SVP, CFO	AAward	+11K sh	—	—	11,000
2023-03-03	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	SVP, CFO	AAward	+11K sh	—	—	11,000
2015-05-04	BLFSBIOLIFE SOLUTIONS INC · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+175K sh	—	—	174,510
2012-02-15	BLFSBIOLIFE SOLUTIONS INC · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+250K sh	—	—	1,000,000
2011-08-17	BLFSBIOLIFE SOLUTIONS INC · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+500K sh	—	—	750,000
2009-03-07	Cardiac Science CORPM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+2,215 sh	—	—	2,215
2009-03-07	Cardiac Science CORPF Tax Payment	VP, Chief Accounting Officer	FTax Payment	−724 sh	$2.75	−$1,991	1,491
2009-03-07	Cardiac Science CORPRestricted Stock UnitsM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−2,215 sh	—	—	6,644

Recent filings

Accepted (ET)
Aug 104
Taylor Daphne0001193125-26-343077
SEC(opens sec.gov)
Aug 84
Taylor Daphne0000950170-25-105938
SEC(opens sec.gov)
Jul 214
Taylor Daphne0000950170-25-097272
SEC(opens sec.gov)
Mar 44
Taylor Daphne0000950170-25-032183
SEC(opens sec.gov)
Aug 94
Taylor Daphne0000950170-24-094813
SEC(opens sec.gov)
Jul 194
Taylor Daphne0000950170-24-084955
SEC(opens sec.gov)
Mar 54
Taylor Daphne0000950170-24-025921
SEC(opens sec.gov)
Jan 304
Taylor Daphne0000950170-24-009005
SEC(opens sec.gov)
Aug 104
Taylor Daphne0001209191-23-045267
SEC(opens sec.gov)

Companies

Address

2401 4TH AVENUE SUITE 1050

SEATTLE, WA, 98121